HeyJaredKelly Bilodeau
- Indexed articles, last 90 days
- 4
- Latest publication
- Aug 3, 2026
- Outlet visibility, for PharmaVoice
- Top 5M sites
- Earliest in this view
- Jul 27, 2026
Latest articles
Trump has another tariff plan to reshore generic drug production. Will it work? (opens the original)
Read excerpt
The president’s most recent tariff proposal gives pharma more time to transition its global supply chain and reshore generic drug production.
Why pharma’s record-setting M&A streak is so unique (opens the original)
Read excerpt
Early-stage candidates, mid-sized companies and of course, Chinese assets, are dominating the dealmaking picture this year.
BMS and Gilead rule in the CAR-T space. Off-the-shelf developers aren’t trying to change that. (opens the original)
Read excerpt
Rather than going head-to-head with approved CAR-T cell therapies, biotechs like Caribou Biosciences are positioning their drugs to fill unique market gaps.
Why 3 secretive biotechs are keeping their science close to the chest (opens the original)
Read excerpt
Startups like Altos Labs are keeping pipeline details scarce to protect their ideas from competitors — but some experts say stealth only works for biotechs with deep pockets.
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 5M sites
For PharmaVoice, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.